InsidersTradesSigma
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by FRIESON RON, Director. Director active across 1 company, notably Akebia Therapeutics, Inc.. In total, 5 filings have been published. History available since 8 June 2022. The latest transaction was disclosed on 17 January 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
5 of 5 declarations
Ron Frieson is a Director at Akebia Therapeutics, Inc. He contributes to corporate governance and the strategic direction of the company. As a board member, he participates in important decision-making and oversight of Akebia's operations. His experience in the biopharmaceutical sector is an asset for the company.